Cargando…
TPH1 A218C polymorphism and temperament in major depression
BACKGROUND: In major depression, one of the candidate genes possibly affecting the risk and severity of symptoms has been found to be tryptophan hydroxylase (TPH1). Variation in treatment response to antidepressive agents according to TPH1 genotype has also been found in several studies. However, th...
Autores principales: | Andre, Kadri, Kampman, Olli, Viikki, Merja, Illi, Ari, Setälä-Soikkeli, Eija, Poutanen, Outi, Mononen, Nina, Leinonen, Esa, Lehtimäki, Terho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704284/ https://www.ncbi.nlm.nih.gov/pubmed/23597148 http://dx.doi.org/10.1186/1471-244X-13-118 |
Ejemplares similares
-
A Cluster Model of Temperament as an Indicator of Antidepressant Response and Symptom Severity in Major Depression
por: Paavonen, Vesa, et al.
Publicado: (2014) -
CYP1A2 polymorphism −1545C > T (rs2470890) is associated with increased side effects to clozapine
por: Viikki, Merja, et al.
Publicado: (2014) -
Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach
por: Anttila, Sami, et al.
Publicado: (2007) -
C-reactive protein and temperament: An instrumental variable analysis
por: Clemens, Ari, et al.
Publicado: (2021) -
Effect of electroconvulsive therapy on brain‐derived neurotrophic factor levels in patients with major depressive disorder
por: Sorri, Annamari, et al.
Publicado: (2018)